コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 for medical histories spanning narcolepsy to axonal neuropathy.
2 ng the GAN transgene) in children with giant axonal neuropathy.
3 usual mutation event in families affected by axonal neuropathy.
4 ur young patients presenting with pure motor axonal neuropathy.
5 of mitochondrial dysfunction in this complex axonal neuropathy.
6 onent of the translation machinery result in axonal neuropathy.
7 , have previously been associated with giant axonal neuropathy.
8 on of GalNacGD1a, in acute motor and sensory axonal neuropathy.
9 essive nature of spinocerebellar ataxia with axonal neuropathy.
10 nerve biopsy showed features of a dystrophic axonal neuropathy.
11 uces a neuropathy that resembles acute motor axonal neuropathy.
12 llum, brain stem and spinal cord and sensory axonal neuropathy.
13 europhysiological evidence of a sensorimotor axonal neuropathy.
14 ollow-up, findings indicative of a preceding axonal neuropathy.
15 einaemic neuropathy and normal or non-immune axonal neuropathy.
16 in TRPV4 have been linked to three distinct axonal neuropathies.
17 otherapy may occur in both demyelinating and axonal neuropathies.
22 hybridoma developed a patchy, predominantly axonal neuropathy affecting a small proportion of nerve
23 oth type 2B disease is an autosomal dominant axonal neuropathy affecting peripheral sensory neurons c
24 he agnostic screening of children with acute axonal neuropathy after an infection, we identified seve
25 nating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN) being the most common forms obs
27 logical findings compatible with acute motor axonal neuropathy (AMAN) type, and had rapid evolution o
28 patients with post-Campylobacter acute motor axonal neuropathy (AMAN) variant of GBS, and immunizatio
30 a antibodies are associated with acute motor axonal neuropathy (AMAN), a form of Guillain-Barre syndr
31 ypes of Guillain-Barre syndrome, acute motor axonal neuropathy (AMAN), and acute motor and sensory ax
32 lyradiculoneuropathy (AIDP) from acute motor axonal neuropathy (AMAN), as classified by electrophysio
33 Guillain-Barre syndrome subform acute motor axonal neuropathy (AMAN), Campylobacter jejuni enteritis
36 uropathy (AMAN), and acute motor and sensory axonal neuropathy (AMSAN), are caused by antibodies to g
37 n understanding the link between acute motor axonal neuropathy and antibodies to GM1, GD1a, GM1b and
41 are in particular implicated in acute motor axonal neuropathy and, with the exception of GalNacGD1a,
42 derlies the pathogenesis of the TRPV4-linked axonal neuropathies, and may have immediate implications
43 gia with thin corpus callosum and peripheral axonal neuropathy, and account for approximately 40% of
44 ia telangiectasia, spastic paraplegia, giant axonal neuropathy, and fumarate hydratase deficiency.
47 ne are associated with ocular motor apraxia, axonal neuropathy, and progressive cerebellar ataxia.
48 and autonomic neuropathy type 1 (HSAN1), an axonal neuropathy associated with several missense mutat
49 to critical illness polyneuropathy (CIP), an axonal neuropathy associated with systemic inflammatory
51 d a mutant mouse with a dominantly inherited axonal neuropathy caused by a Gars mutation that is infe
52 spinal muscular atrophy type V (dSMA-V) are axonal neuropathies characterized by a phenotype that is
53 in 2 unrelated families with the hereditary axonal neuropathy Charcot-Marie-Tooth disease type 2 (CM
54 with an autosomal-dominant inherited form of axonal neuropathy, Charcot-Marie-Tooth disease type 2N (
55 ciated with SMARD1, milder alleles cause the axonal neuropathy, Charcot-Marie-Tooth disease type 2S (
56 progressive X-linked recessive disorder with axonal neuropathy, deafness, and cognitive impairment.
58 rological conditions, including a subtype of axonal neuropathy due to ATP7A mutations and the late-on
59 from 12 families who had severe, acute-onset axonal neuropathy following infection (13 female and 11
60 d children affected by a severe, acute-onset axonal neuropathy following infection through an interna
67 ch on pathogenic mechanisms underlying giant axonal neuropathy (GAN), a disease caused by a deficienc
68 ative diseases, but none as clearly as giant axonal neuropathy (GAN), a ravaging disease caused by mu
69 udied the molecular mechanisms causing giant axonal neuropathy (GAN), a severe neurodegenerative dise
70 ations in gigaxonin were identified in giant axonal neuropathy (GAN), an autosomal recessive disorder
75 dentification of these new genetic causes of axonal neuropathy has not only been important for patien
76 th anti-ganglioside antibodies and a primary axonal neuropathy, has raised many questions about the s
78 months; (2) electrophysiological evidence of axonal neuropathy in at least two nerves without any evi
80 a confirmed that a mutation in MPZ can cause axonal neuropathy, in the absence of segmental demyelina
83 ot-Marie-Tooth disease type 2D, a hereditary axonal neuropathy, is caused by mutations in glycyl-tRNA
84 athological mechanisms underlying this novel axonal neuropathy might overlap with those of amyotrophi
86 d decarboxylase [AADC] deficiency, and giant axonal neuropathy), ocular disorders (Leber congenital a
87 order manifesting a predominant sensorimotor axonal neuropathy, optic atrophy and cognitive deficit.
88 t instead causes spinocerebellar ataxia with axonal neuropathy (SCAN1) by affecting large, terminally
89 ived either from spinocerebellar ataxia with axonal neuropathy (SCAN1) patients, who have an inactiva
90 (TDP1) can cause spinocerebellar ataxia with axonal neuropathy (SCAN1), a neurodegenerative syndrome
91 erited disorder, spinocerebellar ataxia with axonal neuropathy (SCAN1), is caused by a H493R mutation
93 autosomal recessive, acute-onset paediatric axonal neuropathy, seemingly triggered by infection, tha
95 res of a case of paralytic rabies with acute axonal neuropathy that closely resembled axonal Guillain
96 ypes, ranging from rapidly progressive fatal axonal neuropathy to mild motor neuropathy with impaired
97 mal dominant family with Charcot-Marie-Tooth axonal neuropathy type 2 (CMT2) with 38 members of which
98 tibodies, are mostly detected in acute motor axonal neuropathy type of GBS and in FS, and less freque
99 weakness, wasting and sensory loss, with an axonal neuropathy typical of CMT2, but no significant re
100 gene transfer with scAAV9/JeT-GAN for giant axonal neuropathy was associated with adverse events and
105 pidly progressive and disabling sensorimotor axonal neuropathy with early small-fibre involvement.
106 mutations, to late-onset autosomal-dominant axonal neuropathy with predominant sensory deficits.
109 udies were suggestive of a motor predominant axonal neuropathy, with reduced conduction velocities in
111 atients with diabetic neuropathy and 10 with axonal neuropathy without vasculopathy were immunostaine